Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Nemera
Nemera
Activities:
Drug Delivery
Medical Devices
Pharmaceutical
X
LinkedIn
Trending Articles
AbbVie and Gedeon Richter join forces to advance neuropsychiatric target R&D
The companies will aim to discover and progress targets for neuropsychiatric disorders
Containment in a high potent manufacturing facility
Throughout the pharmaceutical industry, there is a lack of consistency regarding the assignment of Occupational Exposure Limits (OELs) to specific bands
Rousselot
Rousselot is the global leader* of collagen-based solutions for the food, health and nutrition, biomedical and pharmaceutical sectors. Working in partnership with our global...
Tabletability, compactability and compressibility: What’s the difference?
To patients and consumers, tablets are a simple and convenient dosage form, but the science behind compressing a block of particles or granules into a single tablet can be...
Causes and solutions for dark spots in tablet manufacturing
Natoli Engineering examines the causes and solutions for dark spots that can halt production
Upcoming event
Lab Innovations
30-31 October 2024 | Exhibition | Birmingham, UK
See all
Related Content
Drug Delivery
Cristalia products with Nemera’s reusable pen injector commercialised in Brazil
Cristalia’s human growth hormone will be administered with CRISPEN, a pen injector designed by Nemera
Manufacturing
Nemera extends manufacturing capabilities in North America
With a newly acquired space in Vernon Hills, Nemera has opened a third location in the US, in addition to the manufacturing facility in Buffalo Grove and Innovation Center in Chicago
Manufacturing
Nemera's manufacturing facility inaugurated in Poland
The total area of the new site covers over 11,000 square metres including a 3,400 square metres clean room space
Finance
Nemera to build drug delivery device facility in Poland
The production plant is being built on an area of 5 hectares with dedicated expandable clean room space
Regulatory
Nemera updates branding and website
“We are thrilled to launch our new identity that re-unites our purpose of putting patients first and our commitment of being a holistic and agile partner”
Manufacturing
BIOMM to commercialise Nemera's reusable insulin pen
BIOMM will market the product under the trade name Lifepen in Brazil, where around 16.8 million people suffer from diabetes
Finance
Nemera to acquire Copernicus
The acquisition establishes Nemera’s operations footprint in Eastern Europe.
Subscribe now